SC 13G/A | 2024-03-06 | PERCEPTIVE ADVISORS LLC | RELMADA THERAPEUTICS, INC. | 0 | 0.0% | EDGAR |
SC 13G/A | 2024-02-14 | RTW INVESTMENTS, LP | RELMADA THERAPEUTICS, INC. | 0 | 0.0% | EDGAR |
SC 13G/A | 2024-02-14 | Deep Track Capital, LP | RELMADA THERAPEUTICS, INC. | 2,044,507 | 6.8% | EDGAR |
SC 13G/A | 2024-02-13 | VANGUARD GROUP INC | RELMADA THERAPEUTICS, INC. | 1,310,805 | 4.4% | EDGAR |
SC 13G/A | 2023-07-07 | BlackRock Inc. | RELMADA THERAPEUTICS, INC. | 605,254 | 2.0% | EDGAR |
SC 13G/A | 2023-02-14 | Point72 Asset Management, L.P. | RELMADA THERAPEUTICS, INC. | 0 | 0.0% | EDGAR |
SC 13G/A | 2023-02-14 | RTW INVESTMENTS, LP | RELMADA THERAPEUTICS, INC. | 2,067,824 | 6.9% | EDGAR |
SC 13G/A | 2023-02-14 | BIOTECHNOLOGY VALUE FUND L P | RELMADA THERAPEUTICS, INC. | 0 | 0.0% | EDGAR |
SC 13G/A | 2023-02-14 | CITADEL ADVISORS LLC | RELMADA THERAPEUTICS, INC. | - | 0.1% | EDGAR |
SC 13G/A | 2023-02-14 | RA CAPITAL MANAGEMENT, L.P. | RELMADA THERAPEUTICS, INC. | 0 | 0.0% | EDGAR |
SC 13G/A | 2023-02-14 | Deep Track Capital, LP | RELMADA THERAPEUTICS, INC. | 2,837,818 | 9.4% | EDGAR |
SC 13G | 2023-02-09 | VANGUARD GROUP INC | RELMADA THERAPEUTICS, INC. | 1,516,980 | 5.0% | EDGAR |
SC 13G/A | 2023-02-01 | BlackRock Inc. | RELMADA THERAPEUTICS, INC. | 1,863,142 | 6.2% | EDGAR |
SC 13G | 2022-12-20 | KOTLER KEVIN | RELMADA THERAPEUTICS, INC. | 1,899,930 | 6.3% | EDGAR |
SC 13G | 2022-10-21 | Deep Track Capital, LP | RELMADA THERAPEUTICS, INC. | 2,481,000 | 8.2% | EDGAR |
SC 13G | 2022-10-17 | Point72 Asset Management, L.P. | RELMADA THERAPEUTICS, INC. | 2,081,300 | 7.3% | EDGAR |
SC 13G | 2022-10-17 | CITADEL ADVISORS LLC | RELMADA THERAPEUTICS, INC. | - | 1.6% | EDGAR |
SC 13G | 2022-09-23 | PERCEPTIVE ADVISORS LLC | RELMADA THERAPEUTICS, INC. | 2,099,952 | 7.0% | EDGAR |
SC 13G/A | 2022-02-14 | RTW INVESTMENTS, LP | RELMADA THERAPEUTICS, INC. | 2,186,324 | 7.9% | EDGAR |
SC 13G | 2022-02-14 | Venrock Healthcare Capital Partners II, L.P. | RELMADA THERAPEUTICS, INC. | 2,270,072 | 8.2% | EDGAR |